Excitotoxic neuronal damage caused by overactivation of N-methyl-D-aspartate glutamate receptors (NMDARs) is thought to be a principal cause of neuronal loss after stroke and brain trauma. Here we report that activation of sterol regulatory element binding protein-1 (SREBP-1) transcription factor in affected neurons is an essential step in NMDAR-mediated excitotoxic neuronal death in both in vitro and in vivo models of stroke. The NMDAR-mediated activation of SREBP-1 is a result of increased insulin-induced gene-1 (Insig-1) degradation, which can be inhibited with an Insig-1–derived interference peptide (Indip) that we have developed. Using a focal ischemia model of stroke, we show that systemic administration of Indip not only prevents SREBP-1 activation but also substantially reduces neuronal damage and improves behavioral outcome. Our study suggests that agents that reduce SREBP-1 activation such as Indip may represent a new class of neuroprotective therapeutics against stroke.
Subscribe to Journal
Get full journal access for 1 year
only $18.75 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Choi, D.W. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11, 465–469 (1988).
Lipton, S.A. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat. Rev. Drug Discov. 5, 160–170 (2006).
Ikonomidou, C. & Turski, L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 1, 383–386 (2002).
Kemp, J.A. & McKernan, R.M. NMDA receptor pathways as drug targets. Nat. Neurosci. 5 (Suppl), 1039–1042 (2002).
Lee, J.M., Zipfel, G.J. & Choi, D.W. The changing landscape of ischaemic brain injury mechanisms. Nature 399, A7–A14 (1999).
Aarts, M. et al. Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Science 298, 846–850 (2002).
Camandola, S. & Mattson, M.P. NF-κB as a therapeutic target in neurodegenerative diseases. Expert Opin. Ther. Targets 11, 123–132 (2007).
Hardingham, G.E., Arnold, F.J. & Bading, H. Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity. Nat. Neurosci. 4, 261–267 (2001).
Hetman, M. & Kharebava, G. Survival signaling pathways activated by NMDA receptors. Curr. Top. Med. Chem. 6, 787–799 (2006).
Rao, V.R. & Finkbeiner, S. NMDA and AMPA receptors: old channels, new tricks. Trends Neurosci. 30, 284–291 (2007).
West, A.E., Griffith, E.C. & Greenberg, M.E. Regulation of transcription factors by neuronal activity. Nat. Rev. Neurosci. 3, 921–931 (2002).
Zhang, S.J. et al. Decoding NMDA receptor signaling: identification of genomic programs specifying neuronal survival and death. Neuron 53, 549–562 (2007).
Zou, J. & Crews, F. CREB and NF-κB transcription factors regulate sensitivity to excitotoxic and oxidative stress induced neuronal cell death. Cell. Mol. Neurobiol. 26, 385–405 (2006).
Espenshade, P.J. & Hughes, A.L. Regulation of sterol synthesis in eukaryotes. Annu. Rev. Genet. 41, 401–427 (2007).
Goldstein, J.L., DeBose-Boyd, R.A. & Brown, M.S. Protein sensors for membrane sterols. Cell 124, 35–46 (2006).
Adibhatla, R.M., Hatcher, J.F. & Dempsey, R.J. Lipids and lipidomics in brain injury and diseases. AAPS J. 8, E314–E321 (2006).
Siesjö, B.K. & Katsura, K. Ischemic brain damage: focus on lipids and lipid mediators. Adv. Exp. Med. Biol. 318, 41–56 (1992).
Sandberg, M.B. et al. Glucose-induced lipogenesis in pancreatic beta cells is dependent on SREBP-1. Mol. Cell. Endocrinol. 240, 94–106 (2005).
Takahashi, A. et al. Transgenic mice overexpressing nuclear SREBP-1c in pancreatic beta cells. Diabetes 54, 492–499 (2005).
Wang, H. et al. The transcription factor SREBP-1c is instrumental in the development of betacell dysfunction. J. Biol. Chem. 278, 16622–16629 (2003).
Wang, H., Kouri, G. & Wollheim, C.B. ER stress and SREBP-1 activation are implicated in beta cell glucolipotoxicity. J. Cell Sci. 118, 3905–3915 (2005).
Yamashita, T. et al. Role of uncoupling protein-2 up-regulation and triglyceride accumulation in impaired glucose-stimulated insulin secretion in a beta cell lipotoxicity model overexpressing sterol regulatory element–binding protein-1c. Endocrinology 145, 3566–3577 (2004).
Chang, Y.C., Bien, C.M., Lee, H., Espenshade, P.J. & Kwon-Chung, K.J. Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in Cryptococcus neoformans. Mol. Microbiol. 64, 614–629 (2007).
Todd, B.L., Stewart, E.V., Burg, J.S., Hughes, A.L. & Espenshade, P.J. Sterol regulatory element binding protein is a principal regulator of anaerobic gene expression in fission yeast. Mol. Cell. Biol. 26, 2817–2831 (2006).
Taghibiglou, C. et al. Essential role of SBP-1 activation in oxygen deprivation induced lipid accumulation and increase in body width/length ratio in Caenorhabditis elegans. FEBS Lett. 583, 831–834 (2009).
Hardingham, G.E., Fukunaga, Y. & Bading, H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat. Neurosci. 5, 405–414 (2002).
Liu, Y. et al. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 27, 2846–2857 (2007).
Zhou, M. & Baudry, M. Developmental changes in NMDA neurotoxicity reflect developmental changes in subunit composition of NMDA receptors. J. Neurosci. 26, 2956–2963 (2006).
Liu, L. et al. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 304, 1021–1024 (2004).
Tigaret, C.M. et al. Subunit dependencies of N-methyl-d-aspartate (NMDA) receptor–induced α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor internalization. Mol. Pharmacol. 69, 1251–1259 (2006).
Mutel, V. et al. In vitro binding properties in rat brain of [3H]Ro 25–6981, a potent and selective antagonist of NMDA receptors containing NR2B subunits. J. Neurochem. 70, 2147–2155 (1998).
Mattson, M.P. Calcium and neurodegeneration. Aging Cell 6, 337–350 (2007).
Wang, X. et al. Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis. EMBO J. 15, 1012–1020 (1996).
Horton, J.D. et al. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Natl. Acad. Sci. USA 100, 12027–12032 (2003).
Horton, J.D. et al. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element–binding protein-2. J. Clin. Invest. 101, 2331–2339 (1998).
Nohturfft, A., Brown, M.S. & Goldstein, J.L. Topology of SREBP cleavage-activating protein, a polytopic membrane protein with a sterol-sensing domain. J. Biol. Chem. 273, 17243–17250 (1998).
Sun, L.P., Li, L., Goldstein, J.L. & Brown, M.S. Insig required for sterol-mediated inhibition of Scap/SREBP binding to COPII proteins in vitro. J. Biol. Chem. 280, 26483–26490 (2005).
Yang, T. et al. Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell 110, 489–500 (2002).
Gong, Y. et al. Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake. Cell Metab. 3, 15–24 (2006).
Lee, J.N., Gong, Y., Zhang, X. & Ye, J. Proteasomal degradation of ubiquitinated Insig proteins is determined by serine residues flanking ubiquitinated lysines. Proc. Natl. Acad. Sci. USA 103, 4958–4963 (2006).
Lee, J.N., Song, B., DeBose-Boyd, R.A. & Ye, J. Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78. J. Biol. Chem. 281, 39308–39315 (2006).
Lee, J.N. & Ye, J. Proteolytic activation of sterol regulatory element–binding protein induced by cellular stress through depletion of Insig-1. J. Biol. Chem. 279, 45257–45265 (2004).
Schwarze, S.R., Ho, A., Vocero-Akbani, A. & Dowdy, S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285, 1569–1572 (1999).
Borsello, T. et al. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat. Med. 9, 1180–1186 (2003).
Liu, X.J. et al. Treatment of inflammatory and neuropathic pain by uncoupling Src from the NMDA receptor complex. Nat. Med. 14, 1325–1332 (2008).
Wong, T.P. et al. Hippocampal long-term depression mediates acute stress-induced spatial memory retrieval impairment. Proc. Natl. Acad. Sci. USA 104, 11471–11476 (2007).
Goldberg, M.P. & Choi, D.W. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J. Neurosci. 13, 3510–3524 (1993).
Bederson, J.B. et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17, 472–476 (1986).
Schmued, L.C., Albertson, C. & Slikker, W. Jr. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 751, 37–46 (1997).
Park, H.J. et al. Role of sterol regulatory element binding proteins in the regulation of Gαi2 expression in cultured atrial cells. Circ. Res. 91, 32–37 (2002).
Park, H.J. et al. Parasympathetic response in chick myocytes and mouse heart is controlled by SREBP. J. Clin. Invest. 118, 259–271 (2008).
Porstmann, T. et al. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 8, 224–236 (2008).
Lee, S.H. et al. Synaptic protein degradation underlies destabilization of retrieved fear memory. Science 319, 1253–1256 (2008).
Mielke, J.G. & Wang, Y.T. Insulin exerts neuroprotection by counteracting the decrease in cell-surface GABA receptors following oxygen-glucose deprivation in cultured cortical neurons. J. Neurochem. 92, 103–113 (2005).
We thank J. Ye (University of Texas Southwestern Medical Center) for myc–Insig-1 plasmid, T. Osborne (University of California–Irvine) for Flag–nt-SREBP-1 and Y. P. Auberson (Novartis Pharma AG) for the generous gift of NVP-AAM077. We also thank J. Wang for his technical support. This work was supported by the Heart and Stroke Foundation of British Columbia and the Yukon, the Canadian Institutes of Health Research and CHDI (Cure Huntington's Disease Initiative) Foundation. Y.T.W. is a Howard Hughes Medical Institute International Scholar and Heart and Stroke Foundation of British Columbia and the Yukon Chair in Stroke Research. C.T. was supported by post-doctoral fellowships from the Canadian Institutes of Health Research and Michael Smith Foundation for Health.
About this article
Cite this article
Taghibiglou, C., Martin, H., Lai, T. et al. Role of NMDA receptor–dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries. Nat Med 15, 1399–1406 (2009). https://doi.org/10.1038/nm.2064
Cationic Arginine-Rich Peptides (CARPs): A Novel Class of Neuroprotective Agents With a Multimodal Mechanism of Action
Frontiers in Neurology (2020)
Hypothermia but not NMDA receptor antagonism protects against stroke induced by distal middle cerebral arterial occlusion in mice
PLOS ONE (2020)
Trends in Molecular Medicine (2020)
Evidence for altered insulin signalling in the brains of Genetic Absence Epilepsy Rats from Strasbourg
Clinical and Experimental Pharmacology and Physiology (2020)
Mutant huntingtin interacts with the sterol regulatory element-binding proteins and impairs their nuclear import
Human Molecular Genetics (2020)